Keap1在肾细胞癌中的表达及其作用

doi:10.6040/j.issn.1671-7554.0.2016.162

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (3): 94-99.doi: 10.6040/j.issn.1671-7554.0.2016.162

Keap1在肾细胞癌中的表达及其作用

史培堃¹,曾贝妮¹,吴伟芳¹,胡晓燕¹,马天加²,周亚滨¹

1.山东大学医学院病原生物学系, 山东济南 250012;2.山东大学第二医院泌尿外科, 山东济南 250033

收稿日期:2016-02-22 出版日期:2017-03-10 发布日期:2017-03-10
通讯作者: 周亚滨. E-mail:zyb@sdu.edu.cn; 马天加. E-mail:sdmttjj@sina.com E-mail:zyb@sdu.edu.cn; sdmttjj@sina.com
基金资助:
山东省重点研发项目(2015GSF118147);山东省自然科学基金(ZR2011HL010)

Expression and role of Keap1 in renal cell carcinoma

SHI Peikun¹, ZENG Beini¹, WU Weifang¹, HU Xiaoyan¹, MA Tianjia², ZHOU Yabin¹

1. Department of Pathogenic Biology, School of Medicine, Shandong University, Jinan 250012, Shandong, China;
2. Department of Urology, Second Hospital of Shandong University, Jinan 250033, Shandong, China

Received:2016-02-22 Online:2017-03-10 Published:2017-03-10

摘要/Abstract

摘要： 目的探讨Kelch样ECH相关蛋白-1(Keap1)在肾癌中的表达及其在肾癌发生发展中的作用。方法采用Q-PCR技术检测32例肾癌患者的肿瘤组织和肾癌旁组织中Keap1、核因子E2相关因子2(NFE2L2)的表达;免疫组织化学染色法检测上述肾癌患者肿瘤组织和肾癌旁组织中Keap1、NFE2L2的表达;CCK-8法检测和克隆形成法检测过表达Keap1后对肾癌细胞系ACHN增殖活性以及克隆形成能力的影响。结果实时荧光定量PCR(Q-PCR)结果显示,75.00%患者Keap1 mRNA的表达癌旁组织高于肿瘤组织(P=0.000),62.50%患者NFE2L2 mRNA的表达肿瘤组织高于癌旁组织(P=0.046)。免疫组化结果显示32例肾癌患者中,Keap1蛋白在癌旁组织(87.50%)的表达高于肿瘤组织(25.00%)(P=0.000),NFE2L2蛋白在肿瘤组织(81.25%)的表达高于癌旁组织(46.88%)(P=0.004)。高表达Keap1后,NFE2L2的表达降低,肾癌细胞系ACHN的增殖能力和克隆形成能力降低。结论 Keap1/NFE2L2通路在肾癌的发生和发展中可能发挥重要作用,Keap1的表达对肾癌可能起到抑制作用。

关键词: 肾细胞癌, 细胞增殖, 核因子E2相关因子2, Kelch样ECH相关蛋白-1

Abstract: Objective To investigate the expression of Keap1 and evaluate its role in renal carcinoma. Methods The total RNA of tumor tissues and adjacent tissues were isolated from 32 cases of renal carcinoma treated during May 2014 to April 2015 by TRIzol. The expressions of Keap1 and NFE2L2 were detected by Q-PCR technology and immunohistochemical staining. The changes of proliferation and colony forming ability of ACHN after overexpressed Keap1 were detected by CCK-8 cell proliferation and clone formation assay. Results Q-PCR results showed that the expression of Keap1 mRNA in adjacent tissues in 75% patients was higher than that in tumor tissues(P=0.000), the expression of NFE2L2 mRNA in tumor tissues in 62% patients was higher than that in adjacent tissues(P=0.046). The immunohistochemical results showed that the expression of Keap1 protein in adjacent tissues(87.50%)was higher than that in tumor tissues(25.00%)(P=0.000), and the expression of NFE2L2 protein in tumor tissues(81.25%)was higher than that in adjacent tissues(46.88%)(P=0.004). Overexpression of Keap1 decreased proliferation and colony forming ability of renal cell carcinoma cell line ACHN. Conclusion The abnormal expression of Keap1 in tumor tissues indicates that the Keap1-NFE2L2 pathway may play an important role in renal carcinoma. Keap1 has a probable inhibiting effect on the progression of renal carcinoma.

Key words: Renal carcinoma, Kelch-like ECH-associated protein1, Proliferation, Nuclear factor E2-related factor 2

中图分类号:

R574

史培堃,曾贝妮,吴伟芳,胡晓燕,马天加,周亚滨. Keap1在肾细胞癌中的表达及其作用[J]. 山东大学学报（医学版）, 2017, 55(3): 94-99.

SHI Peikun, ZENG Beini, WU Weifang, HU Xiaoyan, MA Tianjia, ZHOU Yabin. Expression and role of Keap1 in renal cell carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 94-99.

参考文献

[1] Brookman-May SD, May M, Shariat SF, et al. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma-results from a comprehensive multi-centre database(CORONA/SATURN-Project)[J]. BJU Int, 2013, 112(7): 909-916.
[2] Huang Y, Li W, Su ZY, et al. The complexity of the Nrf2 pathway: beyond the antioxidant response[J]. J Nutr Biochem, 2015, 26(12): 1401-1413.
[3] OConnell MA, Hayes JD. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic[J]. Biochem Soc Trans, 2015, 43(4): 687-689.
[4] Leinonen HM, Kansanen E, Polonen P, et al. Role of the Keap1-Nrf2 pathway in cancer[J]. Adv Cancer Res, 2014, 122: 281-320. doi: 10.1016/B978-0-12-420117-0.00008-6.
[5] Leinonen HM, Kansanen E, Polonen P, et al. Dysregulation of the Keap1-Nrf2 pathway in cancer[J]. Biochem Soc Trans, 2015, 43(4): 645-649.
[6] Kobayashi A, Kang MI, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2[J]. Mol Cell Biol, 2004, 24(16): 7130-7139.
[7] Guo Y, Yu S, Zhang C, et al. Epigenetic regulation of Keap1-Nrf2 signaling[J]. Free RadicBiol Med, 2015, 88(Pt B): 337-349.
[8] Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity[J]. J Biol Chem, 1991, 266(18): 11632-11639.
[9] Tian H, Zhang B, Di J, et al. Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL[J]. Cancer Letters, 2012, 325(1): 26-34.
[10] Zhao CR, Gao ZH, Qu XJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention[J]. Cancer Epidemiol, 2010, 34(5): 523-533.
[11] Padmanabhan B, Tong KI, Ohta T, et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer[J]. Mol Cell, 2006, 21(5): 689-700.
[12] Wang R, An J, Ji F, et al. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues[J]. Biochem Biophys Res Commun, 2008, 373(1): 151-154.
[13] 曹宝山, 朱翔, 陈森, 等. Keap1在非小细胞肺癌中的表达及与化疗疗效相关性的研究[J]. 中国肺癌杂志, 2012, 15(10): 591-596. CAO Baoshan, ZHU Xiang, CHEN Sen, et al. Keap1 expression for predicting the chemoresistance and prognosis of advanced non-small cell lung cancer[J]. Chinese Journal of Lung Cancer, 2012, 15(10): 591-596.
[14] 张凯茹, 闫惠琴, 王燕, 等. Nrf2及其靶基因在人肺腺癌A549顺铂耐药细胞株中的表达和意义[J]. 中国肺癌杂志, 2009, 12(11): 1150-1154. ZHANG Kairu, YAN Huiqin, WANG Yan, et al. Expression and significance of Nrf2 and its target genes in pulmonary adenocarcinoma A549 cells resistant to cisplatin[J]. Chinese Journal of Lung Cancer, 2009, 12(11): 1150-1154.
[15] Ohta T, Iijima K, Miyamoto M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth[J]. Cancer Res, 2008, 68(5): 1303-1309.
[16] Shim GS, Manandhar S, Shin DH, et al. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway[J]. Free RadicBiol Med, 2009, 47(11): 1619-1631.
[17] Huang CF, Zhang L, Ma SR, et al. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma[J]. PLoS One, 2013, 8(12): e83479. doi: 10.1371/journal.pone.0083479. eCollection 2013.

相关文章 15

[1]	宋艳艳,左淑英. 透明细胞肾细胞癌颌下腺转移1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(7): 120-124.
[2]	王莉莎,王上增,史栋梁,张仲博,任博文,王云飞,郭中华,周晓宁. 乌头汤对膝骨关节炎大鼠模型的治疗作用[J]. 山东大学学报 (医学版), 2024, 62(5): 64-71.
[3]	刘洋,陈贵海. 寒痉汤对冷刺激诱导主动脉平滑肌细胞氧化应激的影响及机制[J]. 山东大学学报 (医学版), 2023, 61(8): 24-30.
[4]	赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[5]	王正阳,夏艳,师凯旋,陶琨,王小杰. 曲美替尼在卵巢癌中对PAX8的表达作用[J]. 山东大学学报 (医学版), 2021, 59(10): 25-31.
[6]	杜甜甜,李娟,赵颖慧,段伟丽,王景,王允山,杜鲁涛,王传新. 长链非编码RNA LINC02474在结直肠癌中的表达特征及对细胞增殖的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 59-69.
[7]	张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[8]	马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32-37.
[9]	熊艺璇,赵斌,贾凌璐,张文静,徐欣. 姜黄素通过Nrf2信号通路促进炎症状态下牙周膜干细胞的成骨分化[J]. 山东大学学报 (医学版), 2020, 58(5): 19-26.
[10]	阎慧丽,魏慕筠,颜磊,赵跃然. FK506结合蛋白52对人子宫内膜间质细胞增殖作用的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 80-87.
[11]	王旭,雷坤阳,梅金红. 甲状腺滤泡癌样肾细胞癌1例[J]. 山东大学学报 (医学版), 2019, 57(11): 115-117.
[12]	李孝峰,杜晓益,刘海南,刘承,范医东. 小檗碱对人肾细胞癌细胞增殖、凋亡、DNA断裂及损伤修复的影响[J]. 山东大学学报 (医学版), 2018, 56(3): 54-59.
[13]	黄平,张坤,李芳,黄国宝,延冰,肖东杰,汪运山,刘华. 脐带和脂肪源性间充质干细胞生物学特性比较[J]. 山东大学学报 (医学版), 2018, 56(3): 72-78.
[14]	李杰,何东,张睿,杨帆,冯少滨,杨依航,辛涛. 核转运蛋白α2在胶质瘤中的表达及对其生物学行为的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 47-54.
[15]	陈希彦,王琪,顾伟亭,文勇. 干扰TAZ基因对舌鳞癌细胞CAL27增殖凋亡的影响及其机制[J]. 山东大学学报 (医学版), 2018, 56(10): 79-85.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

Keap1在肾细胞癌中的表达及其作用

Expression and role of Keap1 in renal cell carcinoma

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

多维度评价

本文评价

推荐阅读 0